AZD-7325

N/A

Report date: 2025/12/22 17:57:56
NME

Base Information

Drug NameAZD-7325
Drug Alias NameAZ-7325AZD-7325BAER-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAutism Spectrum DisorderAnxiety DisordersAnxiety +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenNetherlands +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAxsome Therapeutics IncAvenue Therapeutics Inc
Inactive CompaniesUniversity College LondonAstrazeneca PlcUniversity Of California, Los Angeles
Active IndicationsAnxietyEpilepsy
Inactive IndicationsAutism Spectrum DisorderAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksN/A